Physician profile
Edward Cho
NPI 1336453406
$8,249.98
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,776 · 2020: $337 · 2021: $1,085 · 2022: $119 · 2024: $1,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,606 · Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,606.21 |
| Food and Beverage | $326.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,250.16 | 2019-2024 | |
| Allergan, INC. | $1,810.95 | 2019-2021 | |
| Intuitive Surgical, INC. | $1,090.93 | 2019 | |
| Conmed Corporation | $800.00 | 2019 | |
| Davol INC. | $402.22 | 2019-2021 | |
| Sirtex Medical INC | $246.65 | 2019-2022 | |
| Ethicon US, LLC | $176.16 | 2019-2021 | |
| Abbott Laboratories | $159.55 | 2019 | |
| Nestle Healthcare Nutrition INC. | $138.29 | 2020-2021 | |
| Novocure INC. | $122.31 | 2019 | |
| Smith+Nephew, INC. | $116.81 | 2020-2021 | |
| Angiodynamics, INC. | $113.41 | 2019-2024 | Nanoknife |
| Curium US LLC | $111.45 | 2020-2021 | |
| Medtronic, INC. | $93.90 | 2021-2024 | Ligasure |
| Takeda Pharmaceuticals U.S.A., INC. | $66.34 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $64.96 | 2021 | |
| Baxter Healthcare | $64.82 | 2019 | |
| Potrero Medical, INC. | $57.86 | 2021 | |
| Merck Sharp & Dohme LLC | $53.19 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $50.56 | 2019 | |
| Vivus LLC | $41.98 | 2021 | |
| Shire North American Group INC | $41.28 | 2019 | |
| Biom'Up France Sas | $26.40 | 2020 | |
| Covidien LP | $25.49 | 2019 | |
| Acacia Pharma INC | $18.72 | 2021 | |
| Tersera Therapeutics LLC | $18.14 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.17 | 2019 | |
| Levita Magnetics International Corp | $15.67 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.50 | 2019 | |
| Kci USA, INC. | $13.39 | 2019 | |
| Acell, INC. | $11.66 | 2020 | |
| Bolder Surgical LLC | $9.44 | 2019 | |
| Reprise Biomedical, INC. | $6.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.